GLRA
Gerald L. Ray & Associates Portfolio holdings
AUM
$802M
This Quarter Return
+7.78%
1 Year Return
+21.01%
3 Year Return
+38.28%
5 Year Return
–
10 Year Return
–
AUM
$633M
AUM Growth
+$633M
(+5.6%)
Cap. Flow
-$4.11M
Cap. Flow
% of AUM
-0.65%
Top 10 Holdings %
Top 10 Hldgs %
31.2%
Holding
315
New
15
Increased
71
Reduced
124
Closed
9
Top Buys
| 1 |
CVS Health
CVS
|
$723K |
| 2 |
Skyworks Solutions
SWKS
|
$681K |
| 3 |
Lockheed Martin
LMT
|
$652K |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
$615K |
| 5 |
Hain Celestial
HAIN
|
$531K |
Top Sells
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
$1.17M |
| 2 |
SNDK
SANDISK CORP
SNDK
|
$1.11M |
| 3 |
HP
HPQ
|
$672K |
| 4 |
Kinder Morgan
KMI
|
$653K |
| 5 |
Regeneron Pharmaceuticals
REGN
|
$474K |
Sector Composition
| 1 | Healthcare | 26.13% |
| 2 | Industrials | 14.36% |
| 3 | Consumer Staples | 11.04% |
| 4 | Financials | 9% |
| 5 | Technology | 8.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MMP
26
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $6.1M | 0.96% |
89,804
-1,055
| -1% | -$71.7K |
|
27
Gilead Sciences
GILD
$140B
| $5.97M | 0.94% |
58,965
+1,550
| +3% | +$157K |
|
28
Pfizer
PFE
$141B
| $5.97M | 0.94% |
194,831
-686
| -0.4% | -$21K |
|
29
Walmart
WMT
$793B
| $5.97M | 0.94% |
291,933
-17,205
| -6% | -$352K |
|
30
Boeing
BA
$176B
| $5.63M | 0.89% |
38,958
-276
| -0.7% | -$39.9K |
|
31
Exxon Mobil
XOM
$477B
| $5.51M | 0.87% |
70,741
-2,060
| -3% | -$161K |
|
|
SNDK
32
DELISTED
SANDISK CORP
SNDK
| $5.45M | 0.86% |
71,695
-14,600
| -17% | -$1.11M |
|
33
Vertex Pharmaceuticals
VRTX
$102B
| $4.94M | 0.78% |
39,270
| – | – |
|
34
Thermo Fisher Scientific
TMO
$183B
| $4.94M | 0.78% |
34,792
+150
| +0.4% | +$21.3K |
|
35
Simon Property Group
SPG
$58.7B
| $4.7M | 0.74% |
24,151
-260
| -1% | -$50.6K |
|
36
Cisco
CSCO
$268B
| $4.52M | 0.71% |
166,335
-1,326
| -0.8% | -$36K |
|
37
Enterprise Products Partners
EPD
$68.9B
| $4.47M | 0.71% |
174,637
-1,148
| -0.7% | -$29.4K |
|
38
Merck
MRK
$210B
| $4.17M | 0.66% |
82,806
+1,083
| +1% | +$54.6K |
|
39
IBM
IBM
$227B
| $4.05M | 0.64% |
30,762
-2,187
| -7% | -$288K |
|
40
Estee Lauder
EL
$33.1B
| $3.98M | 0.63% |
45,234
| – | – |
|
41
AT&T
T
$208B
| $3.91M | 0.62% |
150,377
+12,178
| +9% | +$316K |
|
|
42
CVS Health
CVS
$93B
| $3.75M | 0.59% |
38,379
+7,400
| +24% | +$723K |
|
43
Acadia Pharmaceuticals
ACAD
$4.34B
| $3.73M | 0.59% |
104,650
+2,140
| +2% | +$76.3K |
|
|
ESRX
44
DELISTED
Express Scripts Holding Company
ESRX
| $3.66M | 0.58% |
41,834
-194
| -0.5% | -$17K |
|
45
Altria Group
MO
$112B
| $3.66M | 0.58% |
62,804
-597
| -0.9% | -$34.8K |
|
|
KSU
46
DELISTED
Kansas City Southern
KSU
| $3.61M | 0.57% |
48,380
+265
| +0.6% | +$19.8K |
|
47
RTX Corp
RTX
$212B
| $3.59M | 0.57% |
59,443
-2,542
| -4% | -$154K |
|
48
Wells Fargo
WFC
$258B
| $3.51M | 0.55% |
64,490
+3,500
| +6% | +$190K |
|
49
Chevron
CVX
$318B
| $3.39M | 0.54% |
37,707
-460
| -1% | -$41.4K |
|
50
Invesco QQQ Trust
QQQ
$364B
| $3.39M | 0.53% |
30,268
+500
| +2% | +$55.9K |
|